The New Combination Docetaxel, Prednisone and Curcumin in Patients with Castration-Resistant Prostate Cancer: A Pilot Phase II Study.
Mahammedi H, Planchat E, Pouget M, Durando X, Curé H, Guy L, Van-Praagh I, Savareux L, Atger M, Bayet-Robert M, Gadea E, Abrial C, Thivat E, Chollet P, Eymard JC.
Mahammedi H, et al. Among authors: gadea e.
Oncology. 2016;90(2):69-78. doi: 10.1159/000441148. Epub 2016 Jan 16.
Oncology. 2016.
PMID: 26771576
Clinical Trial.